Elanco Animal Health (ELAN) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Elanco Animal Health

ELAN in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Elanco Animal Health makes medicines and preventive products for pets and farm animals, including flea and tick treatments, vaccines and pain therapies sold under brands such as Seresto and Galliprant. It also supplies feed additives and antibiotics for cattle, swine and poultry. The company sells through distributors, retailers and directly to farmers and vets, and is based in Indianapolis.
Where it sits in the stack
Elanco carries no seat in Rubin or Halo, so it sits outside the AI build-out entirely. It belongs to the Healthcare sector of our universe, in the animal-health and specialty-pharmaceutical sleeve, tracked for its own drug-cycle and farm-demand dynamics rather than any AI layer.
Who it is priced against
Closelook's peer group is not set for Elanco. The comparison the market draws is with Zoetis, the larger animal-health company that competes across the same pet and livestock categories.
Why Closelook tracks it
Elanco holds a seat in the Russell 1000 but none in Rubin or Halo, and it carries no Closelook score. The diary has not yet quoted or mentioned it in an edition.
What the diary watches
The diary watches whether the stock's slide against its short and long-term averages continues or steadies, since that would show whether the recent pressure is easing or building.

Elanco Animal Health (ELAN) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for ELAN, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Drug Manufacturers - Specialty & Generic · United States · 5 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ELAN on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Elanco Animal Health (ELAN)?

Elanco Animal Health trades as ELAN on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is ELAN in a Closelook index?

Not currently — Elanco Animal Health is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does ELAN trade against its moving averages?

Mixed moving-average stack: Trades -6.8% vs the 50-day and -4.3% vs the 200-day average, 18.7% below the 52-week high and +24.8% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Elanco Animal Health do?

Elanco Animal Health makes medicines and preventive products for pets and farm animals, including flea and tick treatments, vaccines and pain therapies sold under brands such as Seresto and Galliprant. It also supplies feed additives and antibiotics for cattle, swine and poultry. The company sells through distributors, retailers and directly to farmers and vets, and is based in Indianapolis. Closelook's peer group is not set for Elanco. The comparison the market draws is with Zoetis, the larger animal-health company that competes across the same pet and livestock categories.

Where does Elanco Animal Health sit in the AI build-out?

Elanco carries no seat in Rubin or Halo, so it sits outside the AI build-out entirely. It belongs to the Healthcare sector of our universe, in the animal-health and specialty-pharmaceutical sleeve, tracked for its own drug-cycle and farm-demand dynamics rather than any AI layer. Elanco holds a seat in the Russell 1000 but none in Rubin or Halo, and it carries no Closelook score. The diary has not yet quoted or mentioned it in an edition.

What does this page show?

A live price chart with SMA overlays and drawing tools for ELAN, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.